PharVision Advisers »

Myriad Genetics shares owned by PharVision Advisers

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $360k 59k 6.15

More positions owned by PharVision Advisers

ExlService Holdings (EXLS)
Delek Us Holdings (DK)
Fiverr Intl Ord Shs (FVRR)
Asana Cl A (ASAN)
Broadcom (AVGO)
Itron (ITRI)
Brinker International (EAT)
Herbalife Com Shs (HLF)
NVIDIA Corporation (NVDA)
Evolv Technologies Hldngs In Com Cl A (EVLV)
Las Vegas Sands (LVS)
Vici Pptys (VICI)
Century Aluminum Company (CENX)
Agilent Technologies Inc C ommon (A)
Vail Resorts (MTN)

View all positions for PharVision Advisers

Top funds holding Myriad Genetics

BlackRock
Vanguard Group
State Street Corporation
Millennium Management
Glenview Captal Management
D. E. Shaw & Co
Jacobs Levy Equity Management
Geode Capital Management
Goldman Sachs Group
Charles Schwab Investment Management
AQR Capital Management
Federated Investors
Dimensional Fund Advisors
Point72 Asset Management
Vestal Point Capital

View all funds holding Myriad Genetics